{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:29:20Z","timestamp":1793399360483,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["Z141100002114050"],"award-info":[{"award-number":["Z141100002114050"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7142149"],"award-info":[{"award-number":["7142149"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["H2501"],"award-info":[{"award-number":["H2501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.amjmed.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T21:02:42Z","timestamp":1503694962000},"page":"1388-1396.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":212,"title":["Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial"],"prefix":"10.1016","volume":"130","author":[{"given":"Yutao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre A.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2017.07.003_bib0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0015","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.14-0321","article-title":"Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation","volume":"147","author":"Guo","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1747493016687579","article-title":"Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami","volume":"12","author":"Cerasuolo","year":"2017","journal-title":"Int J Stroke"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.14-2018","article-title":"Time trends of aspirin and warfarin use on stroke and bleeding events in Chinese patients with new-onset atrial fibrillation","volume":"148","author":"Guo","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","article-title":"The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2","volume":"69","author":"Huisman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/heartjnl-2016-309832","article-title":"Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation","volume":"103","author":"Camm","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.acvd.2014.01.001","article-title":"Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey","volume":"107","author":"Gamra","year":"2014","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1160\/TH16-10-0757","article-title":"Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants","volume":"117","author":"Raparelli","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0065","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIR.0000000000000232","article-title":"Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association","volume":"132","author":"Burke","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/eurheartj\/ehv416","article-title":"e-Health: a position statement of the European Society of Cardiology","volume":"37","author":"Cowie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0080","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ijcard.2012.12.047","article-title":"The atrial fibrillation knowledge scale: development, validation and results","volume":"168","author":"Hendriks","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1185\/03007990802619425","article-title":"The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease","volume":"25","author":"McHorney","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.2004.05074.x","article-title":"The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation","volume":"126","author":"Khan","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0095","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0100","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0105","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euv269","article-title":"Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0110","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jgs.14099","article-title":"Using an atrial fibrillation decision support tool for thromboprophylaxis in atrial fibrillation: effect of sex and age","volume":"64","author":"Eckman","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ahj.2016.02.009","article-title":"Impact of an atrial fibrillation decision support tool on thromboprophylaxis for atrial fibrillation","volume":"176","author":"Eckman","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5603\/CJ.a2017.0003","article-title":"Pilot of a computerised antithrombotic risk assessment tool version 2 (CARATV2.0) for stroke prevention in atrial fibrillation","volume":"24","author":"Wang","year":"2017","journal-title":"Cardiol J"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ahj.2017.02.009","article-title":"Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): rationale and design of a cluster randomized trial in the primary care setting","volume":"187","author":"Karlsson","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0135","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0140","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1186\/s40064-016-3722-z","article-title":"Direct new oral anticoagulants: follow-up, guidelines and bleeding complications in general practice-a survey of Swiss general internal medicine practitioners","volume":"5","author":"Sauter","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0145","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/europace\/euv233","volume":"17","author":"Lane","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.thromres.2017.03.002","article-title":"Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: a qualitative study","volume":"153","author":"Clarkesmith","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0155","doi-asserted-by":"crossref","first-page":"e74037","DOI":"10.1371\/journal.pone.0074037","article-title":"Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial","volume":"8","author":"Clarkesmith","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2017.07.003_bib0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2017.03.024","article-title":"Factors associated with non\u2013vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)","volume":"189","author":"Steinberg","year":"2017","journal-title":"Am Heart J"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431730712X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431730712X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:28:29Z","timestamp":1762079309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293431730712X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S000293431730712X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.07.003","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}